Lessee, Operating Lease, Liability, to be Paid, Year Two in USD of LEAP THERAPEUTICS, INC. from Q1 2019 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Leap Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two history and change rate from Q1 2019 to Q3 2023.
  • Leap Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending September 30, 2023 was $268K, a 40.7% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Two, YoY Quarterly Change (%)

LEAP THERAPEUTICS, INC. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2023 $268K -$184K -40.7% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $268K -$184K -40.7% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $339K +$302K +816% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $452K +$415K +1122% Dec 31, 2022 10-K 2023-03-24
Q3 2022 $452K +$343K +315% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $452K +$233K +106% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $37K -$290K -88.7% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $37K -$109K -74.7% Dec 31, 2021 10-K 2022-03-11
Q3 2021 $109K -$325K -74.9% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $219K -$215K -49.5% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 $327K -$107K -24.7% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $146K -$288K -66.4% Dec 31, 2020 10-K 2021-03-12
Q3 2020 $434K -$98K -18.4% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $434K -$98K -18.4% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $434K -$98K -18.4% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 $434K Dec 31, 2019 10-K 2020-03-16
Q3 2019 $532K Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $532K Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $532K Mar 31, 2019 10-Q 2019-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.